Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Blood Type as a Predictor of High-Grade Dysplasia and Associated Malignancy in Patients with Intraductal Papillary Mucinous Neoplasms.

Poruk KE, Griffin J, Makary MA, He J, Cameron JL, Weiss MJ, Wood LD, Goggins M, Wolfgang CL.

J Gastrointest Surg. 2019 Mar;23(3):477-483. doi: 10.1007/s11605-018-3795-9. Epub 2018 Sep 4.

2.

The Beneficial Effects of Minimizing Blood Loss in Pancreatoduodenectomy.

Seykora TF, Ecker BL, McMillan MT, Maggino L, Beane JD, Fong ZV, Hollis RH, Jamieson NB, Javed AA, Kowalsky SJ, Kunstman JW, Malleo G, Poruk KE, Soares K, Valero V 3rd, Velu LKP, Watkins AA, Vollmer CM Jr; Pancreas Fistula Study Group.

Ann Surg. 2019 Jul;270(1):147-157. doi: 10.1097/SLA.0000000000002714.

PMID:
29489483
3.

Circulating Epithelial Cells in Intraductal Papillary Mucinous Neoplasms and Cystic Pancreatic Lesions.

Poruk KE, Valero V 3rd, He J, Ahuja N, Cameron JL, Weiss MJ, Lennon AM, Goggins M, Wood LD, Wolfgang CL.

Pancreas. 2017 Aug;46(7):943-947. doi: 10.1097/MPA.0000000000000869.

PMID:
28697136
4.

The use of negative pressure wound therapy to prevent post-operative surgical site infections following pancreaticoduodenectomy.

Burkhart RA, Javed AA, Ronnekleiv-Kelly S, Wright MJ, Poruk KE, Eckhauser F, Makary MA, Cameron JL, Wolfgang CL, He J, Weiss MJ.

HPB (Oxford). 2017 Sep;19(9):825-831. doi: 10.1016/j.hpb.2017.05.004. Epub 2017 Jun 8.

5.

Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy.

Ecker BL, McMillan MT, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Dickson EJ, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Javed AA, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, Poruk KE, Salem RR, Schmidt CR, Soares K, Stauffer JA, Valero V, Velu LKP, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

Ann Surg. 2018 Apr;267(4):608-616. doi: 10.1097/SLA.0000000000002327.

PMID:
28594741
6.

Ventral hernia repair in patients with abdominal loss of domain: an observational study of one institution's experience.

Azar FK, Crawford TC, Poruk KE, Farrow N, Cornell P, Nadra O, Azoury SC, Soares KC, Cooney CM, Eckhauser FE.

Hernia. 2017 Apr;21(2):245-252. doi: 10.1007/s10029-017-1576-0. Epub 2017 Feb 8.

PMID:
28181089
7.

Creation of a novel risk score for surgical site infection and occurrence after ventral hernia repair.

Poruk KE, Hicks CW, Trent Magruder J, Rodriguez-Unda N, Burce KK, Azoury SC, Cornell P, Cooney CM, Eckhauser FE.

Hernia. 2017 Apr;21(2):261-269. doi: 10.1007/s10029-016-1547-x. Epub 2016 Dec 18.

PMID:
27990572
8.

Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma.

Poruk KE, Blackford AL, Weiss MJ, Cameron JL, He J, Goggins M, Rasheed ZA, Wolfgang CL, Wood LD.

Clin Cancer Res. 2017 Jun 1;23(11):2681-2690. doi: 10.1158/1078-0432.CCR-16-1467. Epub 2016 Oct 27.

9.

Effect of hernia size on operative repair and post-operative outcomes after open ventral hernia repair.

Poruk KE, Farrow N, Azar F, Burce KK, Hicks CW, Azoury SC, Cornell P, Cooney CM, Eckhauser FE.

Hernia. 2016 Dec;20(6):805-810. doi: 10.1007/s10029-016-1542-2. Epub 2016 Oct 26.

PMID:
27785629
10.

Primary Tumor Resection Following Favorable Response to Systemic Chemotherapy in Stage IV Pancreatic Adenocarcinoma with Synchronous Metastases: a Bi-institutional Analysis.

Wright GP, Poruk KE, Zenati MS, Steve J, Bahary N, Hogg ME, Zuriekat AH, Wolfgang CL, Zeh HJ 3rd, Weiss MJ.

J Gastrointest Surg. 2016 Nov;20(11):1830-1835. Epub 2016 Sep 7.

PMID:
27604886
11.

A novel, validated risk score to predict surgical site infection after pancreaticoduodenectomy.

Poruk KE, Lin JA, Cooper MA, He J, Makary MA, Hirose K, Cameron JL, Pawlik TM, Wolfgang CL, Eckhauser F, Weiss MJ.

HPB (Oxford). 2016 Nov;18(11):893-899. doi: 10.1016/j.hpb.2016.07.011. Epub 2016 Sep 10.

12.

Long-term outcomes of sandwich ventral hernia repair paired with hybrid vacuum-assisted closure.

Hicks CW, Poruk KE, Baltodano PA, Soares KC, Azoury SC, Cooney CM, Cornell P, Eckhauser FE.

J Surg Res. 2016 Aug;204(2):282-287. doi: 10.1016/j.jss.2016.04.072. Epub 2016 May 10.

PMID:
27565062
13.

Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesis.

Hackeng WM, Brosens LA, Poruk KE, Noë M, Hosoda W, Poling JS, Rizzo A, Campbell-Thompson M, Atkinson MA, Konukiewitz B, Klöppel G, Heaphy CM, Meeker AK, Wood LD.

Hum Pathol. 2016 Oct;56:93-100. doi: 10.1016/j.humpath.2016.06.006. Epub 2016 Jun 21.

PMID:
27342911
14.

Is It Time to Expand the Role of Total Pancreatectomy for IPMN?

Griffin JF, Poruk KE, Wolfgang CL.

Dig Surg. 2016;33(4):335-42. doi: 10.1159/000445019. Epub 2016 May 25. Review.

15.

Palliative Management of Unresectable Pancreas Cancer.

Poruk KE, Wolfgang CL.

Surg Oncol Clin N Am. 2016 Apr;25(2):327-37. doi: 10.1016/j.soc.2015.11.005. Epub 2016 Feb 17. Review.

PMID:
27013367
16.

Functioning inferior vena cava filter caught in the act.

Poruk KE, Reifsnyder T.

J Vasc Surg Venous Lymphat Disord. 2015 Oct;3(4):446. doi: 10.1016/j.jvsv.2015.01.002. No abstract available.

PMID:
26992624
17.

Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.

Poruk KE, Valero V 3rd, Saunders T, Blackford AL, Griffin JF, Poling J, Hruban RH, Anders RA, Herman J, Zheng L, Rasheed ZA, Laheru DA, Ahuja N, Weiss MJ, Cameron JL, Goggins M, Iacobuzio-Donahue CA, Wood LD, Wolfgang CL.

Ann Surg. 2016 Dec;264(6):1073-1081.

18.

Individualized Performance Feedback to Surgical Residents Improves Appropriate Venous Thromboembolism Prophylaxis Prescription and Reduces Potentially Preventable VTE: A Prospective Cohort Study.

Lau BD, Arnaoutakis GJ, Streiff MB, Howley IW, Poruk KE, Beaulieu R, Ellison TA, Van Arendonk KJ, Kraus PS, Hobson DB, Holzmueller CG, Black JH 3rd, Pronovost PJ, Haut ER.

Ann Surg. 2016 Dec;264(6):1181-1187.

PMID:
26649586
19.

Surgery for oligometastasis of pancreatic cancer.

Lu F, Poruk KE, Weiss MJ.

Chin J Cancer Res. 2015 Aug;27(4):358-67. doi: 10.3978/j.issn.1000-9604.2015.05.02. Review.

20.

Pancreatic cancer surgery: past, present, and future.

Griffin JF, Poruk KE, Wolfgang CL.

Chin J Cancer Res. 2015 Aug;27(4):332-48. doi: 10.3978/j.issn.1000-9604.2015.06.07. Review.

21.

The effect of TISSEEL fibrin sealant on seroma formation following complex abdominal wall hernia repair: a single institutional review and derived cost analysis.

Azoury SC, Rodriguez-Unda N, Soares KC, Hicks CW, Baltodano PA, Poruk KE, Hu QL, Cooney CM, Cornell P, Burce K, Eckhauser FE.

Hernia. 2015 Dec;19(6):935-42. doi: 10.1007/s10029-015-1403-4. Epub 2015 Jul 8.

PMID:
26152522
22.

Perioperative Management of Hilar Cholangiocarcinoma.

Poruk KE, Pawlik TM, Weiss MJ.

J Gastrointest Surg. 2015 Oct;19(10):1889-99. doi: 10.1007/s11605-015-2854-8. Epub 2015 May 29. Review.

23.

The current state of surgery for pancreatic cancer.

Poruk KE, Weiss MJ.

Minerva Gastroenterol Dietol. 2015 Jun;61(2):101-15. Epub 2015 Feb 5. Review.

PMID:
25651834
24.

What is the Significance of Indeterminate Pulmonary Nodules in Patients Undergoing Resection for Pancreatic Adenocarcinoma?

Poruk KE, Kim Y, Cameron JL, He J, Eckhauser FE, Rezaee N, Herman J, Laheru D, Zheng L, Fishman EK, Hruban RH, Pawlik TM, Wolfgang CL, Weiss MJ.

J Gastrointest Surg. 2015 May;19(5):841-7. doi: 10.1007/s11605-014-2740-9. Epub 2015 Jan 17.

25.

Screening for pancreatic cancer.

Poruk KE, Firpo MA, Mulvihill SJ.

Adv Surg. 2014;48:115-36. Review.

PMID:
25293611
26.

Breast cancer recurrence after nipple-sparing mastectomy: one institution's experience.

Poruk KE, Ying J, Chidester JR, Olson JR, Matsen CB, Neumayer L, Agarwal J.

Am J Surg. 2015 Jan;209(1):212-7. doi: 10.1016/j.amjsurg.2014.04.001. Epub 2014 May 4.

PMID:
24946727
27.

Young woman with massive splenomegaly.

Poruk KE, Mayo SC, Cornell P, Eckhauser FE.

JAMA Surg. 2014 Aug;149(8):869-70. doi: 10.1001/jamasurg.2013.3209. No abstract available.

PMID:
24919875
28.

Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma.

Poruk KE, Firpo MA, Scaife CL, Adler DG, Emerson LL, Boucher KM, Mulvihill SJ.

Pancreas. 2013 Mar;42(2):193-7. doi: 10.1097/MPA.0b013e31825e354d.

29.

The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates.

Poruk KE, Gay DZ, Brown K, Mulvihill JD, Boucher KM, Scaife CL, Firpo MA, Mulvihill SJ.

Curr Mol Med. 2013 Mar;13(3):340-51. Review.

30.

Screening for pancreatic cancer: why, how, and who?

Poruk KE, Firpo MA, Adler DG, Mulvihill SJ.

Ann Surg. 2013 Jan;257(1):17-26. doi: 10.1097/SLA.0b013e31825ffbfb. Review.

31.

Observational study of caloric and nutrient intake, bone density, and body composition in infants and children with spinal muscular atrophy type I.

Poruk KE, Davis RH, Smart AL, Chisum BS, Lasalle BA, Chan GM, Gill G, Reyna SP, Swoboda KJ.

Neuromuscul Disord. 2012 Nov;22(11):966-73. doi: 10.1016/j.nmd.2012.04.008. Epub 2012 Jul 23.

32.

Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma.

Poruk KE, Firpo MA, Huerter LM, Scaife CL, Emerson LL, Boucher KM, Jones KA, Mulvihill SJ.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2605-10. doi: 10.1158/1055-9965.EPI-10-0178. Epub 2010 Aug 20.

33.

YKE4 (YIL023C) encodes a bidirectional zinc transporter in the endoplasmic reticulum of Saccharomyces cerevisiae.

Kumánovics A, Poruk KE, Osborn KA, Ward DM, Kaplan J.

J Biol Chem. 2006 Aug 11;281(32):22566-74. Epub 2006 Jun 7.

Supplemental Content

Loading ...
Support Center